Skip to main navigation Skip to search Skip to main content

Novel heterocyclic glucocorticoids: In vitro profile and in vivo efficacy

  • Christopher F. Thompson
  • , Nazia Quraishi
  • , Amjad Ali
  • , James R. Tata
  • , Milton L. Hammond
  • , James M. Balkovec
  • , Monica Einstein
  • , Lan Ge
  • , Georgianna Harris
  • , Theresa M. Kelly
  • , Paul Mazur
  • , Shilpa Pandit
  • , Joseph Santoro
  • , Ayesha Sitlani
  • , Chuanlin Wang
  • , Joanne Williamson
  • , Douglas K. Miller
  • , Ting Ting D. Yamin
  • , Chris M. Thompson
  • , Edward A. O'Neill
  • Dennis Zaller, Michael J. Forrest, Ester Carballo-Jane, Silvi Luell
  • Merck

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Abstract

A series of novel ligands for the glucocorticoid receptor containing two heterocycles were synthesized. These compounds were investigated for a dissociative profile using transrepression and transactivation assays. Several compounds were tested in vivo and showed the ability to reduce inflammation in a mouse.

Original languageEnglish
Pages (from-to)2163-2167
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume15
Issue number8
DOIs
StatePublished - 15 Apr 2005

Keywords

  • Dissociation
  • Glucocorticoid
  • Inflammation
  • Transactivation
  • Transrepression

Fingerprint

Dive into the research topics of 'Novel heterocyclic glucocorticoids: In vitro profile and in vivo efficacy'. Together they form a unique fingerprint.

Cite this